Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Bertagnolli is committed to making clinical trials faster, more inclusive and more responsive.
Accelerated progress is needed to achieve Cancer Moonshot goal of cutting the age-adjusted cancer death rate by at least 50% over 25 years.
The American Cancer Society and ACS CAN applaud the pick. Bertagnolli, an oncologist, has been running the National Cancer Institute.
The National Cancer Plan offers a road map for collaboration across cancer programs and bolsters the goals of the Cancer Moonshot.
Cases of the most common type of liver cancer, hepatocellular carcinoma, are on the rise.
People who have had COVID-19 appear to be protected against reinfection for at least a few months.
This new test could “play an important role” in screening people who are at risk for developing hepatocellular carcinoma.
The American Cancer Society sets the record straight.
Ned Sharpless has been appointed interim head of the regulatory agency after the unexpected resignation of the commissioner.
The University of Kentucky has received a multimillion grant from the federal government to do just that.
Building a diverse biomedical sciences workforce is a critical step in reducing the burden of cancer for an increasingly diverse America.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.